Lymphocytic Choriomeningitis Virus Meningoencephalitis from a Household Rodent Infestation — Minnesota, 2015

Please note: An erratum has been published for this report. To view the erratum, please click here.

Pamela Talley, MD1,2; Stacy Holzbauer, DVM2,3; Kirk Smith, DVM2; William Pomputius, MD4 (View author affiliations)

View suggested citation
Article Metrics
Altmetric:
Citations:
Views:

Views equals page views plus PDF downloads

Related Materials

On April 20, 2015, a female aged 15 years sought care at her pediatrician’s office after 5 days of fever, myalgia, left parietal headache, and photophobia. A rapid influenza assay was negative, and erythrocyte sedimentation rate and total white blood cell count were normal. She improved with symptomatic care at home, but returned to her pediatrician’s office on April 28, reporting recurrence of her headache and photophobia and new onset of a stiff neck. She was admitted to the hospital, where she was febrile to 102.9°F (39.4°C) and had meningismus. Computed tomography scan of her head was normal, and a cerebrospinal fluid (CSF) analysis showed a markedly elevated white blood cell count with 68% lymphocytes, low glucose, and a negative Gram stain. She was treated empirically for both bacterial and herpes simplex virus meningitis. The patient’s hospital course was notable for hypotension (blood pressure 81/50), irritability, and pancreatitis with a peak lipase of 8,627 U/L. CSF cultures yielded no growth, and CSF polymerase chain reaction (PCR) testing for herpes simplex virus was negative. Nucleic acid amplification testing, acid-fast bacilli stain, and acid-fast bacilli cultures of CSF were negative for Mycobacterium tuberculosis. Results of investigations for human immunodeficiency virus, syphilis, Lyme disease, human herpesvirus 6 and 7, and species of Babesia, Toxoplasma, Histoplasma, Cryptococcus, Blastomyces, and Brucella were negative. She recovered and was discharged on hospital day 11 with no apparent sequelae.

The case was reported to the Minnesota Department of Health’s Unexplained Critical Illnesses and Deaths Project,* which provides testing for cases that appear likely to have infectious etiologies although usual laboratory assays do not identify an etiologic agent; specimens collected during the hospitalization were submitted. Serum collected on hospital day 4 was reported to be positive for lymphocytic choriomeningitis virus (LCMV) antibody by immunofluorescence assay at a commercial reference laboratory (Table). CDC’s Viral Special Pathogens Branch was consulted because of the uncommon diagnosis and to determine whether this illness represented acute infection. Serologic testing by enzyme-linked immunosorbent assay at CDC showed an immunoglobulin M titer of >1/6,400, consistent with recent infection ( Table).

The Minnesota Department of Health initiated an investigation to identify the source of infection, determine whether additional persons were at risk, and develop recommendations to prevent additional cases. A recently ill family member tested negative for LCMV antibody. No pregnant women resided in the duplex apartment. The family had reported a rat infestation to the treating medical team during hospitalization; subsequent home inspection by a Minnesota Department of Health investigator revealed mouse droppings in the kitchen pantry. The fecal pellets tested positive for LCMV (1) by PCR, implicating the mouse infestation as the likely source of the patient’s infection. A 2006 case report from Michigan identified household rodents as the source of a human LCMV infection, which was confirmed through necropsy, serology, and tissue testing of trapped mice; fecal pellet testing in that case was negative for LCMV (2). This is the first report to identify LCMV-infected mice through fecal pellet testing.

The family was referred for integrated pest management services through the U.S. Department of Housing and Urban Development Healthy Homes program. The city housing inspector performed an urban rodent survey, and the property owner complied with orders to have professional exterminators treat the apartment within 30 days. Both households in the duplex were provided with educational materials concerning prevention of rodent reinfestation.

In the United States, an etiologic agent is identified in <50% of meningoencephalitis cases (3); some undiagnosed cases might be caused by LCMV. LCMV is a virus of the Arenaviridae family; its primary host is the house mouse, Mus musculus. The disease burden in humans is unknown; an estimated 5% of U.S. house mice carry LCMV (4). Human infection occurs by inhalation of aerosolized urine and droppings of infected rodents (5). The virus is a fetal teratogen, and transplacental vertical transmission with severe effects on infants has been described (6); infection after solid organ transplant (79) also have been reported.

This investigation suggests fecal pellet testing as a possible first step in an environmental LCMV investigation when rodent trapping and conducting necropsy for diagnostics are difficult or impractical. Public health action around home rodent infestation might be warranted when LCMV infections in households are detected. Collaboration among clinicians, public health investigators, and local housing authorities can facilitate integrated pest management to decrease the risk for LCMV infection.

Acknowledgments

Polo Chen, MD, Children’s Hospitals and Clinics of Minnesota; Stephanie Yendell, DVM, Paw Htoo, Minnesota Department of Health; Jim Yannarelly, Saint Paul-Ramsey County Department of Public Health; Ute Stroeher, PhD, Barbara Knust, DVM, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC.

Corresponding author: Pamela Talley, ptalley@cdc.gov, 651-201-5193.


1Epidemic Intelligence Service, CDC; 2Minnesota Department of Health, St. Paul; 3Career Epidemiology Field Officer Program, CDC; 4Children’s Hospitals and Clinics of Minnesota.

References

  1. IDEXX BioResearch. Impact rodent pathogen testing. http://www.idexxbioresearch.com/impact-testing
  2. Foster ES, Signs KA, Marks DR, et al. Lymphocytic choriomeningitis in Michigan. Emerg Infect Dis 2006;12:851–3. CrossRef PubMed
  3. Bloch KC, Glaser CA. Encephalitis surveillance through the emerging infections program, 1997–2010. Emerg Infect Dis 2015;21:1562–7. CrossRef PubMed
  4. CDC. Lymphocytic choriomeningitis fact sheet. Atlanta, GA: US Department of Health and Human Services, CDC. http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/Fact_Sheets/Lymphocytic_Choriomeningitis_Fact_Sheet.pdf
  5. Knust B, Ströher U, Edison L, et al. Lymphocytic choriomeningitis virus in employees and mice at multipremises feeder-rodent operation, United States, 2012. Emerg Infect Dis 2014;20:240–7. CrossRef PubMed
  6. Bonthius DJ. Lymphocytic choriomeningitis virus: an underrecognized cause of neurologic disease in the fetus, child, and adult. Semin Pediatr Neurol 2012;19:89–95. CrossRef PubMed
  7. Fischer SA, Graham MB, Kuehnert MJ, et al. ; LCMV in Transplant Recipients Investigation Team. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006;354:2235–49. CrossRef PubMed
  8. Amman BR, Pavlin BI, Albariño CG, et al. Pet rodents and fatal lymphocytic choriomeningitis in transplant patients. Emerg Infect Dis 2007;13:719–25. CrossRef PubMed
  9. Schafer IJ, Miller R, Ströher U, Knust B, Nichol ST, Rollin PE. Notes from the field: a cluster of lymphocytic choriomeningitis virus infections transmitted through organ transplantation—Iowa, 2013. MMWR Morb Mortal Wkly Rep 2014;63:249. PubMed

Return to your place in the textTABLE. Laboratory findings associated with lymphocytic choriomeningitis virus (LCMV) infection in a patient with meningoencephalitis, by specimen collection date — Minnesota, April–August 2015
Clinical specimen/Laboratory test Reference range Collection date
April 28 May 2 May 4 May 21 August 6
Cerebrospinal fluid
White blood cells/µL 0–10 1,287 688
Red blood cells/µL 0–10 108 1,186
Lymphocytes (%) <70 68 89
Glucose (mg/dL) 45–80 36 26
Protein (mg/dL) 15–40 94 150
Serum
LCMV IgM antibodies (IFA)* <1:10 1:40 1:20
LCMV IgG antibodies (IFA)* <1:10 1:1,280 1:2,560
LCMV IgM antibodies (ELISA) <1/100 =1/6,400 =1/6,400 =1/6,400
LCMV IgG antibodies (ELISA) <1/100 <1/100 <1/100 =1/400

Abbreviations: ELISA = enzyme-linked immunosorbent assay; IFA = immunofluorescence assay; IgG = immunoglobulin G; IgM = immunoglobulin M.
*Commercial reference laboratory.
CDC Viral Special Pathogens Branch laboratory.


Suggested citation for this article: Talley P, Holzbauer S, Smith K, Pomputius W. Notes from the Field. Lymphocytic Choriomeningitis Virus Meningoencephalitis from a Household Rodent Infestation — Minnesota, 2015. MMWR Morb Mortal Wkly Rep 2016;65:248–249. DOI: http://dx.doi.org/10.15585/mmwr.mm6509a4.

MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

View Page In: PDF [82K]